Stryker Corporation (SYK) : Capital Advantage reduced its stake in Stryker Corporation by 7.43% during the most recent quarter end. The investment management company now holds a total of 2,504 shares of Stryker Corporation which is valued at $289,387 after selling 201 shares in Stryker Corporation , the firm said in a disclosure report filed with the SEC on Aug 10, 2016.Stryker Corporation makes up approximately 0.08% of Capital Advantage’s portfolio.
Other Hedge Funds, Including , Lafleur Godfrey boosted its stake in SYK in the latest quarter, The investment management firm added 502 additional shares and now holds a total of 92,751 shares of Stryker Corporation which is valued at $10,719,233. Stryker Corporation makes up approx 3.02% of Lafleur Godfrey’s portfolio.Rand Wealth reduced its stake in SYK by selling 2,721 shares or 16.06% in the most recent quarter. The Hedge Fund company now holds 14,220 shares of SYK which is valued at $1,633,878. Stryker Corporation makes up approx 0.21% of Rand Wealth’s portfolio.Polaris Greystone Financial Group boosted its stake in SYK in the latest quarter, The investment management firm added 13,813 additional shares and now holds a total of 130,979 shares of Stryker Corporation which is valued at $15,039,009. Stryker Corporation makes up approx 2.29% of Polaris Greystone Financial Group’s portfolio.Professional Advisory Services Inc boosted its stake in SYK in the latest quarter, The investment management firm added 24,045 additional shares and now holds a total of 148,117 shares of Stryker Corporation which is valued at $18,013,990. Stryker Corporation makes up approx 4.01% of Professional Advisory Services Inc’s portfolio.
Stryker Corporation opened for trading at $113.32 and hit $113.8 on the upside on Friday, eventually ending the session at $113.77, with a gain of 0.02% or 0.02 points. The heightened volatility saw the trading volume jump to 8,81,320 shares. Company has a market cap of $42,584 M.
On the company’s financial health, Stryker Corporation reported $1.24 EPS for the quarter, beating the analyst consensus estimate by $ 0.04 according to the earnings call on Apr 20, 2016. Analyst had a consensus of $1.20. The company had revenue of $2495.00 million for the quarter, compared to analysts expectations of $2471.86 million. The company’s revenue was up 4.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.11 EPS.
Investors should note that on Jul 27, 2016, Stryker Corporation announced a cash dividend of $0.3800. The company’s management has announced Sep 28, 2016 as the ex-dividend date and fixed the record date on Sep 30, 2016. The payable date has been fixed on Oct 31, 2016.
Many Wall Street Analysts have commented on Stryker Corporation. Stryker Corporation was Initiated by Guggenheim to “Buy” on Jun 9, 2016.
Stryker Corporation is a medical technology company. The Company offers a range of products and services in Orthopaedics Medical and Surgical and Neurotechnology and Spine which help improve patient and hospital outcomes.